NEOGENOMICS INC - NOTE 1.250% 5/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q2 2025

Type / Class
Debt / NOTE 1.250% 5/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NEOGENOMICS INC - NOTE 1.250% 5/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q2 $0 $0 -$175,098,016 0
2025 Q1 $176,083,000 $175,632,974 -$7,235 99.31% 14
2024 Q4 $175,544,000 $173,154,965 +$181,204 98.25% 14
2024 Q3 $175,394,000 $172,273,794 +$561,342 97.58% 9
2024 Q2 $174,994,000 $170,404,550 -$25,457,182 97.08% 10
2024 Q1 $201,074,000 $195,598,871 -$2,059,751 96.94% 10
2023 Q4 $204,560,000 $192,833,401 -$1,205,901 93.75% 13
2023 Q3 $205,844,000 $192,127,169 +$1,397 93.41% 12
2023 Q2 $202,364,500 $192,478,250 +$43,410 93.65% 17
2023 Q1 $217,051,000 $202,649,728 +$16,108,001 93.03% 19
2022 Q4 $190,278,150 $161,135,556 -$15,358,224 84.81% 22
2022 Q3 $151,254,500 $139,957,907 +$27,248,907 86.4% 19
2022 Q2 $119,190,500 $109,615,810 -$64,422,922 83.76% 16
2022 Q1 $201,947,000 $184,656,725 -$14,683,460 85.87% 20
2021 Q4 $207,695,000 $246,561,576 +$1,097,259 118.7% 17
2021 Q3 $205,357,000 $303,735,098 +$3,172,374 147.93% 18
2021 Q2 $200,523,000 $285,296,864 -$3,838,553 142.19% 19
2021 Q1 $202,630,000 $304,515,044 -$2,066,940 150.37% 19
2020 Q4 $203,046,000 $329,207,700 -$13,207,687 162.55% 21
2020 Q3 $211,287,000 $263,504,429 +$39,548,658 124.98% 19
2020 Q2 $183,461,170 $197,852,453 +$197,852,453 107.8% 22